basmisanil (RG1662) / Roche 
Welcome,         Profile    Billing    Logout  
 12 Diseases   1 Trial   1 Trial   83 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
basmisanil (RG1662) / Roche
NCT05307679 / 2021-003791-13: A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

Terminated
2
7
Europe, US
Basmisanil, Placebo
Hoffmann-La Roche, F.Hoffmann-La Roche Ltd
Dup15q Syndrome
03/24
03/24

Download Options